Concepedia

Linlin Ma

LM

Statistics

Publications

47

Citations

2K

H-Index

27

Active since

2002

Affiliations

Shanghai University of Medicine and Health Sciences(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Capital Medical University

Novartis (China)

Tongji University

Linlin Ma is an author at Shanghai University of Medicine and Health Sciences specializing in life sciences, molecular virology, and virology.

ORCID

Publications per year

2002–2024

47

Publications

47

Tumor suppressor miR-424-5p abrogates ferroptosis in ovarian cancer through targeting ACSL4

Linlin Ma, Lin Liang, Dan Zhou et al. · Neoplasma · 2020 · 135 citations · Full text

, , +14

Marked Prolongation of Cardiac Allograft Survival by Dendritic Cells Genetically Engineered with NF-κB Oligodeoxyribonucleotide Decoys and Adenoviral Vectors Encoding CTLA4-Ig

Catherine A. Bonham, Lansha Peng, Xiaoyan Liang et al. · The Journal of Immunology · 2002 · 125 citations · Full text

, , +16

Preclinical development of a novel CD47 nanobody with less toxicity and enhanced anti-cancer therapeutic potential

Linlin Ma, Min Zhu, Junwei Gai et al. · Journal of Nanobiotechnology · 2020 · 114 citations · Full text

, , +17

Luteolin decreases the yield of influenza A virus in vitro by interfering with the coat protein I complex expression

Haiyan Yan, Linlin Ma, Huiqiang Wang et al. · Journal of Natural Medicines · 2019 · 111 citations

, , +13

A potent neutralizing nanobody against SARS‐CoV‐2 with inhaled delivery potential

Junwei Gai, Linlin Ma, Guanghui Li et al. · MedComm · 2021 · 101 citations · Full text

, , +16

1–5 of 47